Search clinical trials for: Bipolar disorder with psychotic features

Total 255961 results

Tufts Medical Center
Duke University; University of South Carolina

Completed

Predictors of Response to Augmentation With Ziprasidone (Geodon®) in Major Depressive Disorder

Depression | Bipolar Disorder
Federal Neuro-Psychiatric Hospital, Yaba

Unknown

Antipsychotic Effects of Sorghum Bicolor (JOBELYN) in the Treatment of Schizophrenia

Schizophrenia and Disorders With Psychotic Features

Nigeria
Massachusetts General Hospital
National Alliance for Research on Schizophrenia and Depression

Terminated

Risks for Insulin Resistance and Metabolic Syndrome Between Major Depressive Disorder (MDD) or MDD With Psychotic Features

Metabolic Syndrome | Major Depressive Disorder | Major Depressive Disorder w/ Psychotic Features

United States
Yale University

Completed

Specialized Treatment Early in Psychosis (STEP) (STEP)

Schizophrenia and Disorders With Psychotic Features

United States
New York State Psychiatric Institute
Pfizer

Completed

Open-label Ziprasidone Study for Psychosis Treatment in Adolescents

Schizoaffective Disorder | Schizophreniform Disorder | Bipolar Disorder | Depressive Disorder, Major | Psychosis

United States
National Institute on Drug Abuse (NIDA)

Completed

Effects of Transdermal Nicotine on Smoking, Craving and Withdrawal in People With Schizophrenia

Schizophrenia | Tobacco Use Disorder | Schizophrenia and Disorders With Psychotic Features

United States
National Institute on Drug Abuse (NIDA)

Completed

Nicotine and Cotinine Levels in Smokers With Schizophrenia and Schizoaffective Disorder - 2

Tobacco Use Disorder | Schizophrenia and Disorders With Psychotic Features

United States
University Hospital, Montpellier

Unknown

Magnesium Variations and Cardiometabolic Risk in Patients With Antipsychotic Drugs

Schizophrenia | Schizoaffective Disorder | Bipolar Disorder

France
Sunovion

Completed

Lurasidone Extended Use Study

Schizophrenia | Bipolar Disorder

Canada, Serbia, Colombia, Czech Republic, India, Lithuania, Slovakia, Ukraine, France, Romania, South Africa, Russian Federation
Fundacio d'Investigacio en Atencio Primaria Jordi...
Carlos III Health Institute

Completed

Effectiveness of a Physical Activity and Diet Program in Patients With Psychotic Disorder (CapiCor) (CapiCor)

Schizophrenic Disorders | Schizoaffective Disorders | Bipolar Disorders

Spain
Azienda ULSS di Verona e Provincia
Universita di Verona; FONDAZIONE CARIVERONA

Completed

Physical Co-morbidity, Poor Health Behaviour and Health Promotion in Verona Patients With Functional Psychoses (PHYSICO-DSM-VR)

Psychotic Disorders | Bipolar Disorders

Italy
Assuta Hospital Systems
Sheba Medical Center

Unknown

Remote Monitoring and Support for Patients With Schizophrenia, Schizoaffective or Bipolar Disorder on Adherence

Schizophrenia | Schizoaffective Disorder | Bipolar Disorder
Pontifical Catholic University of Argentina

Completed

Clinical Registry of Patients Under Treatment With Atypical Antipsychotics

Schizophrenia | Major Depressive Disorder | Bipolar Depressive Disorder | Parkinson's Disease With Hallucinations
Brown University
National Institute on Drug Abuse (NIDA)

Completed

Contingent Incentives Plus Bupropion for Smoking in People With Schizophrenia

Tobacco Use Disorder | Schizophrenia and Disorders With Psychotic Features

United States
Duke University
Merck Sharp & Dohme LLC

Completed

Antidepressant Plus Asenapine Versus Antidepressant Plus Placebo for Depression

Major Depressive Disorder Without Psychotic Features

United States
University Hospital of North Norway
SensoDetect

Completed

Auditory Brainstem Response as a Diagnostic Tool in Schizophrenia and Bipolar Disorder

Schizophrenia | Bipolar Disorder | Attention Deficit Disorder With Hyperactivity

Norway
US Department of Veterans Affairs

Completed

Smoking Cessation for Veterans With Severe and Persistent Mental Illness

Schizophrenia | Schizoaffective Disorder | Affective Disorders, Psychotic | Affective Psychosis, Bipolar

United States
Temple University Collaborative on Community Inclusion

Completed

Assessing the Impact of Self-directed Care, Within a Medicaid-funded Environment,on Participation and Community Living

Schizophrenia | Bipolar Disorder | Major Depression
US Department of Veterans Affairs

Completed

A Brief Community Linkage Intervention for Dually Diagnosed Individuals (TLC)

Substance-Related Disorders | Psychotic Disorders | Schizophrenia | Bipolar Disorder

United States
Otsuka Pharmaceutical Development & Commercialization...

Withdrawn

Adherence to Treatment, Safety and Tolerability Study of the Medical Information Device #1 (MIND1) in Subjects With Schizophrenia or Bipolar I Disorder

Nervous System Diseases | Schizophrenia | Mental Disorder | Bipolar 1 Disorder

United States
US Department of Veterans Affairs

Completed

Improving Antipsychotic Adherence Among Patients With Serious Mental Illness

Schizophrenia | Schizoaffective Disorder | Bipolar Disorder

United States
Solvay Pharmaceuticals
Wyeth is now a wholly owned subsidiary of Pfizer; H. Lundbeck A/S

Completed

Progressively Decreasing Titration Schedules of Bifeprunox in Subjects With Schizophrenia or Bipolar Disorder

Schizophrenia | Schizoaffective Disorder | Bipolar Disorder

United States
Dartmouth-Hitchcock Medical Center

Completed

Evaluation of A Statewide Program to Prevent Early Mortality and to Promote Fitness in Persons With SMI

Schizophrenia | Schizoaffective Disorder | Bipolar Disorder

United States
Dartmouth-Hitchcock Medical Center

Completed

Evaluation of the In SHAPE Fitness Intervention for Adults With Serious Mental Illness

Schizophrenia | Schizoaffective Disorder | Bipolar Disorder | Major Depressive Disorder

United States
Eli Lilly and Company

Completed

Study in Adolescents With Schizophrenia or Bipolar Disorder

Schizophrenia | Bipolar I Disorder

Puerto Rico, Russian Federation, United States, Poland
University of Illinois at Chicago
National Institute of Mental Health (NIMH)

Completed

Medication Adherence in Schizophrenia: Development of a CBT-Based Intervention

Psychotic Disorders | Schizophrenia

United States
Lone Baandrup
Glostrup University Hospital, Copenhagen; Copenhagen Trial Unit, Center for...

Completed

Melatonin Versus Placebo for Benzodiazepine Discontinuation in Patients With Schizophrenia (SMART)

Schizophrenia | Schizoaffective Disorder | Bipolar Affective Disorder

Denmark
Dartmouth-Hitchcock Medical Center
National Institutes of Health (NIH)

Completed

Individually Based Psychosocial Rehabilitation for Older People With Serious Mental Illness (SMI)

Schizophrenia | Schizoaffective Disorder | Bipolar Disorder | Major Depression

United States
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Drug Interaction Study of Valproic Acid and Paliperidone Extended-Release (ER) in Patients With Schizophrenia, Bipolar I Disorder, or Schizoaffective Disorder

Psychotic Disorders | Schizophrenia | Bipolar Disorder

United States
Dartmouth-Hitchcock Medical Center
National Institute of Mental Health (NIMH)

Completed

Health Promotion and Fitness for Younger and Older Adults With SMI (InSHAPE)

Schizophrenia | Schizoaffective Disorder | Bipolar Disorder

United States
Otsuka Pharmaceutical Development & Commercialization...

Completed

Open-Label Observational Pilot Study to Evaluate the Pharmacokinetics of Aripiprazole in Subjects With Bipolar 1 Disorder or Schizophrenia

Schizophrenia | Mental Disorder | Bipolar 1 Disorder | Nervous System Disorders

United States
AstraZeneca

Completed

Physician Survey on Monitoring of Patients Treated With Quetiapine

Schizophrenia | Bipolar Disorder | Major Depressive Disorder
AstraZeneca

Completed

EMR Data to Assess Monitoring of Patients Treated With Quetiapine

Schizophrenia | Bipolar Disorder | Major Depressive Disorder
Northwell Health
National Institutes of Health (NIH)

Withdrawn

Study of the Efficacy of Adjunctive Lithium Treatment for the Treatment of Psychotic Mania

Bipolar I Disorder

United States
University of North Carolina, Chapel Hill
Bristol-Myers Squibb

Completed

Body Mass Index (BMI) and Metabolic Changes Following Switch to Aripiprazole From Olanzapine, Risperidone and Quetiapine

Mood Disorders | Schizophrenia | Schizoaffective Disorder | Schizophreniform Disorder
Centre de Recherche de l'Institut Universitaire...

Unknown

Investigator Initiated Study - Asenapine Early Psychosis

Disorders | Schizophrenia and Disorders With Psychotic Features

Canada
Otsuka Pharmaceutical Development & Commercialization...

Terminated

Trial Comparing the Effects of Aripiprazole With Those of Standard of Care on Non-HDL Cholesterol in Patients With Schizophrenia or Bipolar I Disorder Who Have Metabolic Syndrome

Schizophrenia | Schizoaffective Disorder | Metabolic Syndrome | Bipolar I Disorder

Canada
Massachusetts General Hospital
National Institute of Mental Health (NIMH)

Withdrawn

Once Weekly D-cycloserine for Schizophrenia

Schizophrenia

United States
Korea Otsuka Pharmaceutical Co., Ltd.

Completed

Efficacy and Safety of Aripiprazole in Patients With Schizophrenia or Bipolar Disorder

Schizophrenia | Bipolar Disorder

Korea, Republic of
Weill Medical College of Cornell University
National Institute of Mental Health (NIMH)

Completed

Study of Pharmacotherapy of Psychotic Depression (STOP-PD)

Major Depressive Disorder With Psychotic Features

United States, Canada
Melbourne Health
National Institute of Mental Health (NIMH)

Completed

Indicated Prevention of Psychotic Disorders With Low-dose Lithium

Psychotic Disorders | Schizophrenia | Bipolar Disorder

Australia
University of Medicine and Dentistry of New Jersey
National Institute of Mental Health (NIMH)

Completed

Measuring Smoking Behavior in People With Schizophrenia and Bipolar Disorder

Schizophrenia | Bipolar Disorder

United States
Dartmouth-Hitchcock Medical Center
National Institute of Mental Health (NIMH)

Completed

Effectiveness of the Screen, Test, Immunize, Reduce Risk, and Refer (STIRR) Intervention for People With Both a Mental and Substance Abuse Disorder

Depression | HIV Infections | Schizophrenia | Schizoaffective Disorder | Bipolar Disorder | Substance Abuse

United States
Hadassah Medical Organization

Completed

Dental Status of Patients With Severe Mental Illness (SMI-DENTAL)

Depression | PTSD | Schizophrenia | Bipolar Disorder

Israel
Ziv Hospital

Unknown

The Antiatherogenic Properties of HDL in Psychiatric Patients With and Without Antipsychotic Therapy

Schizophrenia | Schizoaffective Disorder | Bipolar Disorder

Israel
AstraZeneca

Completed

Quetiapine Fumarate (SEROQUEL) in the Treatment of Adolescent Patients With Schizophrenia and Bipolar I Disorder (ANCHOR 150)

Schizophrenia | Bipolar I Disorder

United States, Russian Federation, Philippines, Malaysia, South Africa, Poland, Serbia, Ukraine, India
Universita di Verona

Completed

A Large Pragmatic Cluster Randomized Controlled Trial of a Multi-element Psychosocial Intervention for Early Psychosis (GETUP-PIANO)

Psychosis

Italy
The University of Texas Health Science Center at...

Completed

Improving Diabetes Risk Factors in Persons With Schizophrenia or Bipolar Disorder by Switching to Ziprasidone

Schizophrenia | Schizoaffective Disorder | Bipolar Disorder

United States
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study to Evaluate the Safety and the Effects of Risperidone Compared With Other Atypical Antipsychotic Drugs on the Growth and Sexual Maturation in Children

Schizophrenia | Bipolar Disorder | Autistic Disorder | Conduct and Other Disruptive Behavior Disorders

United States, Belgium, Germany, Poland, Greece, Netherlands
Otsuka Pharmaceutical Development & Commercialization...

Completed

Aripiprazole Open-Label, Safety and Tolerability Study (APEX 241)

Schizophrenia | Bipolar Disorder

United States

Search clinical trials for: Bipolar disorder with psychotic features

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kuwait

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations